期刊文献+

类风湿因子免疫吸附剂的制备及性能研究 被引量:1

Preparation and properties of immunoadsorbent for rheumatoid factors
下载PDF
导出
摘要 目的制备一种类风湿因子(RF)免疫吸附剂并研究其性能。方法利用悬浮聚合法制备出大孔聚乙烯醇(PVA)树脂,以此为载体接枝苯丙氨酸,制备出可用于血液灌流吸附的RF免疫吸附剂(PVA-P树脂),通过体外吸附实验观察不同处理方法对RF吸附性能的影响。通过体外血液学实验和溶血实验观察该吸附剂的血液相容性。结果免疫吸附剂的体外吸附实验表明,免疫吸附剂对RF的吸附清除率达到60%以上,处理工艺对RF吸附性能无明显影响。体外血液相容性实验结果表明:免疫吸附剂对红细胞、血小板、总蛋白的影响差异有统计学意义(P<0.05),其他血液指标差异无统计学意义(P>0.05),与日本同类吸附RF产品平行比较,对血细胞的影响差异无统计学意义(P>0.05)。结论 PVA-P树脂作为RF免疫吸附剂具有良好的临床应用前景。 Objective To develope an adsorbent for removing the rheumatoid factor(RF) from the blood of rheumatoid arthritis patients,and study its characteristics.Methods The macroporous polyvinyl alcohol(PVA) microspheres was prepared by suspension polymerization and L-phenylalanine was immobilized as ligand for the beads to form the adsorbent.The adsorption performance of the adsorbent was evaluated in vitro by the static adsorption methods.The blood compatibility performance of the adsorbent was evaluated by hemolysis in vitro experiments and experimental hematology.Results The results showed that the removal percentage of RF by the absorbent was more than 60 % in vitro.The RF process had no effect on adsorption of RF.In vitro blood compatibility results showed that there were significant differences of the effects on red blood cells,platelets and total protein,but there was no difference of the effect on other blood parameters compared the PVA-P resin with Japanese similar products.There were no static difference of the effects on red blood cells.Conclusion It is demonstrated that PVA-P resin as immunoabsorbent for RF has a good prospect in clinical application.
出处 《生物医学工程与临床》 CAS 2010年第5期378-382,共5页 Biomedical Engineering and Clinical Medicine
关键词 免疫吸附剂 类风湿因子 类风湿性关节炎 聚乙烯醇微球 苯丙氨酸 immunoadsorbent rheumatoid factors rheumatoid arthritis polyvinyl alcohol microsphere phenylalanine
  • 相关文献

参考文献12

  • 1Dorner RW,Alexander RL,Moore TL,et al.Rheumatoid facto-rs[J].Clin Chim Acta,1987,167(1):1-21.
  • 2Yamazaki Z,Fujimori Y,Iizuka I,et al.Effect of immunoadso-rption on patient with rheumatoid arthritis or SLE[J].Trans Am Soc Artif Intern Organs,1984,30:211-216.
  • 3Kold G.Rapid adsorption of reheumatoid(RF) on suspension of glutaradehype-crosslinked immunoglobulin G(IgG)--a method to avoid RF interference[J].Biomater Artif Cells Artif Organs,1990,18(5):605-609.
  • 4Balint JP Jr.Immue modulation associated with extracoporeal immunoadsorption treatment utilizing protein A/silica columns[J].Artif Organs,1996,20(8):906-913.
  • 5王永健,王连永,俞耀庭.类风湿关节炎吸附剂的制备及间隔臂作用的研究[J].中国生物医学工程学报,2005,24(4):486-491. 被引量:2
  • 6Hughes LB,Moreland LW.New therapeutic approaches to the management of rheumatoid arthritis[J].BioDrugs,2001,15(6):379-393.
  • 7Matic G,Bosch T,Ramlow W.Background and indications for p-rotein A-based extracorporeal immunoadsorption[J].Ther Ap-her,2001,5(5):394-403.
  • 8Hailey D,Topfer LA.Extracorporeal immunoadsorption treatm-ent for rheumatoid arthritis[J].Issues Emerg Health Technol,2002,28:1-4.
  • 9Griffiths RI,Slurzberg JE.Cost-effectiveness of prosorba colu-mn therapy for rheumatoid arthritis:a framework for analysis[J].Ther Apher,2001,5(2):105-110.
  • 10付春晓,陈长治,俞耀庭,吕宪禹.对类风湿因子具有高反应活性的热聚IgG的制备[J].中国免疫学杂志,2000,16(3):145-146. 被引量:7

二级参考文献19

  • 1边宝娟,夏彦平,许效松.YTS-200碳肾技术在抢救急性药物中毒中的应用[J].中国血液净化,2002,1(6):39-40. 被引量:5
  • 2许晨,卢灿辉.壳聚糖季铵化衍生物的吸湿性与保湿性[J].应用化学,1996,13(5):94-96. 被引量:44
  • 3Hughes LB,Moreland LW.New therapeutic approaches to the management of rheumatoid arthritis[J],BioDrugs,2001,15(6):379-393.
  • 4Goran Matic,Thomas Bosch,Wolfgang Ramlow.Background and indications for protein A-based extracorporeal immunoadsorption[J],Therapeutic Apheresis,2001,5(5):394-403.
  • 5Hailey D,Topfer LA.Extracorporeal immunoadsorption treatment for rheumatoid arthritis[J].Issues Emerg Health Technol,2002,(28):1.
  • 6Griffiths RI,Slurzberg JEF Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: A framework for analysis [J],Therapeutic Apheresis, 2001,5(2):105-110.
  • 7Fu CX,Yu YT,Chen CZ,A novel immunoadsorbent for rheumatoid arthritis therapy-Preparation and efficacy evalution[J],Artif.Cells Blood Subsit.Iimmobil.Biotechnol.,2000,28(5):409-414.
  • 8Yamazaki Z,Idezuki Y,Inoue N,et al.Extracorporeal immunoadsorption with IM-PH or IM-TR column[J].Biomater Artif Cells Artif Organs,1989,17(2):117-124.
  • 9Tomalia DA,Majoros I.Supramolecular Polymers(Ciferri,A.,ed.)[M],Marcel Decker,2000:359-435.
  • 10Fischer M,Vgtle F.Dendrimers:From design to application-A progress report[J].Angew.Chem.,Int.Ed.Engl.1999,38(7):885-905.

共引文献19

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部